The article discusses a study on the satisfaction and quality of life associated with inhaled insulin for the treatment of type 1 diabetes mellitus. It was noted that type 1 diabetic patients receiving premeal inhaled insulin have greater satisfaction and quality of life (QOL) than those getting ...
Type 1 diabetes mellitus (DM) imposes a heavy toll on society, due to its high prevalence and mortality, and the acute and chronic complications associated with it. At the 64th annual scientific sessions of the American Diabetes Association (ADA) [Orlando, Florida, US; Jun 2004], a team ...
Insulin lispro shows its worth in type 1 DMInsulin lispro shows its worth in type 1 DMThe model showed that the insulin lispro arm would be associated with an increase in mean life expectancy of 0.06 years, and a mean quality-adjusted life-year ( QALY ) increase of 0.105, compared with ...
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal-bolus regimen. Fast-acting insulin analogues (FAIAs) reduce hypoglycaemia and improve administration flexibility compared with short-acting human insulin (SHI). This ...
1.a hormone, produced by the beta cells of the islets of Langerhans of the pancreas, that regulates the metabolism of glucose and other nutrients. 2.any of several commercial preparations of this substance, each absorbed into the body at a particular rate: used for treating diabetes. ...
To examine disordered eating, insulin misuse, weight change, and their relationships with glycemic control and diabetic complications in adolescents with type 1 diabetes followed up over eight years.Of 76 adolescents (43 male, 33 female) with type 1 diabetes aged 11-18 years at the first assessme...
The target glycated hemoglobin A1c (HbA1c) for all children with type 1 diabetes mellitus (T1DM), including preschool children, is recommended to be < 7.5% (< 58 mmol/mol)(Grade B, EL I) Show more Long-Term Glycemic and Metabolic Control ...
Type 1 DM patients depend on exogenous administration of insulin (most commonly injected subcutaneously) for their survival because the insulin is no longer produced endogenously. Type 2 DM patients are insulin-resistant, have relatively low insulin production due to the decline in β-cell function,...
The author reflects on the applications of non-insulin therapies for type I diabetes. Topics discussed include treatment of type I diabetes with the help of sulfonylureas (SFUs), metformin and thiazolidinediones (TZDs), introduction of new non-insulin agents for treatment including glucagon-like pept...
作者: DM Kendall 摘要: The effective use of insulin in clinical practice remains an important clinical challenge for many practitioners. Indeed, insulin treatment is often delayed or withheld in patients with type 2 diabetes, and most practitioners appreciate that insulin-treated patients often have ...